Vitamin D deficiency is associated with community-acquired clostridium difficile infection: a case–control study

被引:0
作者
Tanya Sahay
Ashwin N Ananthakrishnan
机构
[1] Massachusetts General Hospital,Division of General Internal Medicine
[2] Massachusetts General Hospital,Division of Gastroenterology
[3] MGH Crohn’s and Colitis center,undefined
来源
BMC Infectious Diseases | / 14卷
关键词
C difficile; Vitamin D; Community-acquired; Infection; Cathelicidin;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 208 条
[1]  
Ananthakrishnan AN(2011)Clostridium difficile infection: epidemiology, risk factors and management Nat Rev Gastroenterol Hepatol 8 17-26
[2]  
Deneve C(2009)New trends in Clostridium difficile virulence and pathogenesis Int J Antimicrob Agents 33 S24-S28
[3]  
Janoir C(2009)Clostridium difficile 30 years on: what has, or has not, changed and why? Int J Antimicrob Agents 33 S2-S8
[4]  
Poilane I(2009)Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes J Infect 58 403-410
[5]  
Fantinato C(2006)Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996–2003 Emerg Infect Dis 12 409-415
[6]  
Collignon A(2009)Renewed interest in a difficult disease: Clostridium difficile infections–epidemiology and current treatment strategies Curr Opin Gastroenterol 25 24-35
[7]  
Gerding DN(2007)The emerging infectious challenge of clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequences Infect Control Hosp Epidemiol 28 1219-1227
[8]  
Johnson S(2009)Review of current literature on the economic burden of Clostridium difficile infection Infect Control Hosp Epidemiol 30 57-66
[9]  
McDonald LC(2004)Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case–control studies CMAJ 171 33-38
[10]  
Owings M(2005)Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease JAMA 294 2989-2995